News from daiichi sankyo europe gmbh A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

( NASDAQ-NMS:ARQL)

Sep 02, 2014, 11:50 ET
PREvention oF thromboembolic events - European Registry in Atrial Fibrillation (PREFER in AF)

One Year Data from the PREFER in AF Registry Show Significant Changes in Atrial Fibrillation (AF) Management in Europe and Implementation of Clinical Guidelines

Registry provides new insights into AF treatment decisions, including patients' quality of life and treatment satisfaction[1],[2] ESC...

May 16, 2014, 07:33 ET

Journée Mondiale de l'Hypertension 2014 : Daiichi Sankyo fait du bien à votre cœur !

  - La Journée Mondiale de l'Hypertension a lieu chaque année le 17 mai. Le thème choisi pour 2014 est "Connaître...

May 15, 2014, 09:54 ET

Giornata Mondiale contro l'Ipertensione Arteriosa 2014

Daiichi Sankyo e "Little Hearts" insieme per gli orfani dell'Est Europa  Il 17 maggio ricorre la decima edizione della Giornata Mondiale...

May 15, 2014, 08:50 ET

Daiichi Sankyo pone en marcha la iniciativa "Haz que tu corazón se sienta bien"

Daiichi Sankyo pone en marcha la iniciativa "Haz que tu corazón se sienta bien" -...

Apr 02, 2014, 07:00 ET

Daiichi Sankyo extends the PREFER in AF patient registry to provide additional insights into the long-term management of patients with atrial fibrillation

For European Media Only, Not for UK Media   Atrial fibrillation (AF) is the most common heart rhythm disorder[1] resulting in a...

Jun 25, 2013, 04:25 ET

23º Congreso de la Sociedad Europea de Hipertensión - ESH 2013

El estudio SEVITENSION demuestra la superioridad de Sevikar® (olmesartán y amlodipino) frente a la combinación de perindopril...

Jun 25, 2013, 04:25 ET

23ème congrès européen sur l'Hypertension et la Protection Cardiovasculaire

De nouvelles données de l'étude SEVITENSION montrent la supériorité de l'association à doses fixes Sevikar®...

Jun 25, 2013, 04:25 ET

Congresso ESH 2013, dallo studio SEVITENSION nuove evidenze sull'efficacia della combinazione fissa olmesartan/amlodipina vs. perindopril/amlodipina nel controllo della pressione arteriosa centrale

Nel corso del 23° Congresso della Società Europea di Ipertensione sono stati presentati gli ultimi dati dello studio SEVITENSION, che...

Feb 06, 2013, 11:29 ET

European patient registry in venous thromboembolism (VTE) - PREFER in VTE - enrols first patient

The registry plans to gather data from more than 4,000 patients with VTE across seven European countries, providing insights into the...

May 15, 2009, 04:00 ET

SHARE Program Launched to Address the Challenges of Achieving Blood Pressure Goal

- Investigating the Real Burden of Hypertension, Addressing the Challenges of Getting to Blood Pressure Goal and SHARE(ing) the...

Oct 01, 2007, 01:00 ET

DAIICHI SANKYO EUROPE is Applying for Approval of its New Combination Product of Olmesartan and Amlodipin

MUNICH, Germany, October 1 /PRNewswire/ -- - New Product Under Development for the Treatment of High Blood Pressure - Approval...